A Study of DII235 in Adults With Elevated Lipoprotein(a)

NCT07235046 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

200

Enrollment

INDUSTRY

Sponsor class

Conditions

Lipoprotein Disorder

Interventions

DRUG: DII235
DRUG: Saline

Sponsor

Novartis Pharmaceuticals